Conditions

The association between 1-year changes in albuminuria and subsequent risk of cardiovascular and renal events. 

Behavioral changes during the pandemic can improve blood glucose control.

Tirzepatide is both a GIP and GLP-1 receptor agonist. 

By Sheri Colberg, PhD
Ever since the US Diabetes Prevention Program (DPP) multicenter trial was completed nearly two decades ago, we have known that it is possible to prevent, or at least delay, prediabetes (an insulin-resistant state) from progressing into full-blown type 2 diabetes.

What is the impact of adjunctive sotagliflozin to insulin therapy on diabetes distress and treatment satisfaction in patients with type 1 diabetes?

Results of an extensive retrospective study indicate a strong association between glomerular filtration (eGFR) rate and cardiovascular disease morbidity rate.

Better understanding of how certain viral infections may increase the incidence of type 1 diabetes could lead to new strategies for prevention. 

What do the new ADA guidelines have to say about treating children and adolescents with type 1 diabetes? 

The diagnosis and treatment of depression in the elderly population with type 2 diabetes are essential for managing dementia risks. 

Many adults with type 2 diabetes carry the burden of complicated medication regimens, associated with worse patient outcomes and a higher potential for drug interactions.